|
|
The Anatomical Therapeutic Chemical (ATC) classification system
|
|
|
|
|
Level 4
L - Antineoplastic and immunomodulating agentsL04 - Immunosuppressive agentsL04A - Immunosuppressive agentsL04AC - Interleukin inhibitors
L04AC01 - DaclizumabL04AC02 - BasiliximabL04AC03 - AnakinraL04AC04 - RilonaceptL04AC05 - UstekinumabL04AC06 - MepolizumabL04AC07 - TocilizumabL04AC08 - CanakinumabL04AC09 - BriakinumabL04AC10 - Secukinumab
|
|
|